Thursday, March 17, 2016 8:41:22 PM
Rules (if you have different proposal, please advise):
- weight: interim announcement (DMC recommendation) - 40% (w1) / Eff% - 40% (w2) / interim event -20% (w3) (if interim event date won't be available: 50-50%)
- difference in days (interim announcement (DMC recommendation) - d1 - and interim event - d3)
- difference in percentage 2 digits, eg. 1.15% diff = 115 score (Eff% - d2)
- d1 x w1+ d2 x w2 (+d3 x w3) = score
- lowest score will win
"Sub-rules" (if you have different proposal, please advise):
- no data = the highest score in the category + 10%
- no date change within 14 days
Feel free to correct or join till update from the Co. (Don't have to guess all, but please keep the order. ie.: June 12 / 25% / na or June 12 / 25% / April 24.)
Please note:
- I changed the date to the next working day if a guess was Saturday, Sunday or (US) Holiday
- If no exact date, I used the middle of te period
...............................................................................................................................................................................
- ziploc_1: na / January 1 (Q4-Q1) / na / na
- gozips: stop / February 15 (Feb) / 35% / December 15 (December)
- marzan: stop / February 24 / 33% / na
- James364202: stop / March 15 (Spring - March) / 45% (40-50%, 50-60% low HDL, high trigs subgroup) / na
- isaeed: cont. / March 15 / na / January 15 (no stop @ interim due to 23-25% eff.)
- Mogwai: cont. / March 15 (mid March) / na / February 5 (early February) - no stop @ interim
- - - - - - - - - - - - - - - - - - - - - - - - - -
- goamrn: stop / April 1 / 31% / February 15
- chas1232123: stop / April 1 / 33% / February 11 (plus or minus a month)
- rydad21: stop / April 1 / na / na
- xblkbk: stop / April 5 / 34% / na
- Hspooner: stop / April 8 /33% / February 15
- Invest83838: stop / April 15 / 39.6% / February 15
- acuzuss: stop / April 17 / 41,00% / January 13
- Pharmacydude: stop / April 22 / 35% / February 29
- Biofalcon: stop / April 26 / 29% / February 16
- golf stud: stop / May 5 / 40.5% / March 18
- annac: stop / May 7 / 27% / March 7
- rafunrafun: stop / May 9 / 38% / February 11 (placebo 5.5%)
- Sam81: stop / May 16 (May) / 27% (>27%) / March 11
- drrc1949: stop / May 16 (May) / 34% / February 29
- Squeck: stop / May 16 / 45% / March 31
- invest2992: Stop / May 16 / 50% / March 30
- HDGabor: stop / May 17 (depends on analysis duration, so April-June) / 36% (30-40%) / February 24 (2nd half of February)
- heysfguy: stop / May 24 / 33% / Feb 2
- Danouse: stop / May 27 / 27% / March 29
- alwayswatching1: stop / May 27 / 41% / na
- Nukemtiltheyglow: stop / May 31 (May-June) / 45% / na
- slowmover: June 8 / 32% / March 3
- mrmainstreet: stop / June 15 (June) / 25% / March 15 (March)
- Repero: stop / June 15 (June) / 29% / March 15 (March)
- oneragman: June 15 (June) / 31% / April 11
- lbwagain: stop / June 15 (mid June) / 34.5% (33-36%) / April 25
- Biobillionair: stop / June 15 (June) / 40% / February 23 (Placebo Rate 5.6% V Event Rate 3.36%)
- Louieblouie: stop / June 17 / 27% / May 2
- Benny7459: stop / June 21 / 42% / April 21
- PghKid1 (from ST): stop / June 22 (June 15-30) / 31% / March 8 (March 1-15)
- Albino2: stop / June 28 (last week of June) / 51% / April 8
- Mochachip: stop/ July 1 / 30% / March 17
- rosemountbomber: stop / July 1 / 33% / na
- zumantu: stop / August 8 / 32% / April 18
- BioChica: stop / August 10 / 40% (>30% / 35-45%) / May 23
- jessellivermore: stop / August 15 (August) / 37.5% (35-40%) / May 2
- FishyFingers: stop / August 16 / 57% (>50%) / May 18
- CaptBeer: stop / September 1 / 43% / June 1
- Whalatane: cont. / September 2 / 20% / June 2
Best,
G
#STRONGERTOGETHER
Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Recent AMRN News
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM